ALLERGAN RETINA COVERAGE CONNECTION Trademark

Trademark Overview

On Wednesday, January 13, 2021, a trademark application was filed for ALLERGAN RETINA COVERAGE CONNECTION with the United States Patent and Trademark Office. The USPTO has given the ALLERGAN RETINA COVERAGE CONNECTION trademark a serial number of 90464343. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, April 29, 2024. This trademark is owned by Allergan, Inc.. The ALLERGAN RETINA COVERAGE CONNECTION trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing business information reporting services about the business administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; customer services, namely, responding to customers' inquiries for others to provide business assistance to patients regarding treatment payment plan options, namely, the business administration of patient reimbursement programs
allergan retina coverage connection

General Information

Serial Number90464343
Word MarkALLERGAN RETINA COVERAGE CONNECTION
Filing DateWednesday, January 13, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesProviding business information reporting services about the business administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; customer services, namely, responding to customers' inquiries for others to provide business assistance to patients regarding treatment payment plan options, namely, the business administration of patient reimbursement programs
NOT AVAILABLE"RETINA COVERAGE"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 14, 2021
Primary Code035
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, US 60064
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, US 92612

Trademark Events

Event DateEvent Description
Wednesday, April 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 22, 2021NON-FINAL ACTION E-MAILED
Saturday, January 16, 2021NEW APPLICATION ENTERED
Tuesday, July 13, 2021ASSIGNED TO EXAMINER
Thursday, July 22, 2021NON-FINAL ACTION WRITTEN
Thursday, July 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 16, 2022SOU EXTENSION 1 GRANTED
Monday, May 16, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 16, 2022SOU EXTENSION 1 FILED
Wednesday, May 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 5, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 5, 2022SOU EXTENSION 2 FILED
Wednesday, October 5, 2022SOU EXTENSION 2 GRANTED
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 3 FILED
Monday, May 15, 2023SOU EXTENSION 3 GRANTED
Monday, October 30, 2023SOU EXTENSION 4 FILED
Monday, October 30, 2023SOU EXTENSION 4 GRANTED
Monday, April 29, 2024SOU EXTENSION 5 FILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 5 GRANTED
Friday, April 5, 2024ASSIGNED TO EXAMINER
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

connection coverage retina allergan business treatment patients payment options namely programs plan regarding administration